January 7, 2010
(AURORA, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP” / OTCQX: “HXBPF) today announced that John Docherty, president and chief operating officer, will present at Biotech Showcase 2010 at 9:40 a.m. PST on
January 13, 2010 at the Marines’ Memorial Club and Hotel in San Francisco. Mr. Docherty will provide an overview of the Company’s leading product development programs L-DOS47 and Topical Interferon Alpha-2b.
The slide show portion of the presentation will be posted on the Company’s website, www.helixbiopharma.com, on January 13, 2010.